octenisept
(0.10 g + 2.00 g)/100 g, solution for the skin
Octenidini dihydrochloridum + Phenoxyethanolum
This medicine should always be used in accordance with the description in the patient leaflet or as directed by a doctor or pharmacist.
Octenisept is a disinfectant solution containing the active substances: octenidine dihydrochloride, phenoxyethanol. Octenisept has bactericidal, fungicidal, and virucidal effects. The microbiological efficacy of the medicine has been extensively documented in both laboratory and clinical studies. The efficacy of the medicine in destroying microorganisms or inactivating viruses occurs after just 1 minute of application. After additional loading with mucous membrane protein under laboratory conditions, the medicine has a destructive effect on bacteria (including Chlamydia and Mycoplasma), fungi, yeast, protozoa (Trichomonas), and viruses (Herpes simplex, inactivates HBV and HIV). The effect of the medicine lasts for an hour, thus providing safety during diagnostic, therapeutic, or surgical procedures. Octenidine dihydrochloride belongs to cationic-active compounds, has two active centers, and acts on the surface of the wound and skin. Phenoxyethanol complements the action of octenidine dihydrochloride, acting in the deeper layers of the skin and mucous membranes. Octenisept is intended for:
Octenisept is intended for use in adults and children of all ages.
If the patient is allergic to octenidine dihydrochloride, phenoxyethanol, or any of the other ingredients of this medicine (listed in section 6). The medicine should not be used for flushing the abdominal cavity.
The medicine is for use on the skin.
The medicine should be used with caution in newborns, especially premature babies. Octenisept may cause severe skin changes. Excess medicine should be removed and ensured that the solution does not remain on the skin longer than necessary (this also applies to materials soaked with the solution that come into direct contact with the patient). The medicine should not be used in the eye. If the medicine comes into contact with the eyes, they should be rinsed immediately with a large amount of water. The medicine is not recommended for use in the ear and should not be swallowed. Octenidine dihydrochloride is more toxic when used intravenously than orally, so it is necessary to avoid the medicine entering the bloodstream in larger quantities, e.g. as a result of accidental injection. Given that octenidine dihydrochloride in octenisept is present in an amount of only 0.1%, the risk of this substance is unlikely.
Octenisept should not be used together with antiseptics based on PVP-iodine (iodine complex with povidone) on adjacent parts of the body, as this may lead to strong brown or even purple discoloration. As a cationic medicine, octenisept may form poorly soluble residues when combined with anionic detergents or soaps. Due to the possibility of interactions with anionic compounds, it is recommended to use distilled water (or water for injections) as a solvent.
There are no clinical trial results on the safety of using the medicine in pregnant and breastfeeding women.
No studies have been conducted on the effect of octenisept on the ability to drive vehicles and operate machinery.
This medicine should always be taken in accordance with the description in the patient leaflet or as directed by a doctor or pharmacist. In case of doubts, you should consult a doctor or pharmacist. Octenisept is recommended for use in an undiluted form. Method of administration: application to the skin. Octenisept should be applied at least once a day to the treated area by spraying, wiping with a sterile swab, or using a dressing to ensure complete moistening. Disinfection of the skin and mucous membraneThe skin and mucous membrane areas to be treated must be thoroughly moistened with a sterile swab soaked in octenisept or moistened by spraying the medicine directly onto the accessible skin and mucous membrane areas. The required exposure time should be observed - at least 1 minute, it is recommended to extend the time to 5 minutes. Attention should be paid to uniform moistening of the entire surface. Leave for at least 1 minute. Supportively in the treatment of fungal skin infections, between the toes, the medicine should be sprayed onto the affected surfaces in the morning and evening for a period of 14 days. Antiseptics for superficial woundsThe wound should be sprayed or wiped with a sterile swab soaked in octenisept. Octenisept should always be used when changing the dressing. In wounds with exudate, octenisept should be used in the form of a dressing, ensuring contact with the wound and its moistening for at least 1 minute, it is recommended to extend the time to 5 minutes. Post-operative suture careThe wound should be sprayed or wiped with a sterile swab soaked in octenisept. Octenisept should always be used when changing the dressing. Octenisept has disinfectant and analgesic effects. Disinfection of the wound area should be performed using sterile swabs soaked in undiluted octenisept, radiating from the center of the wound outwards. Mucous membrane antiseptics of the vaginaThe surfaces of the vaginal mucous membrane should be moistened with octenisept, ensuring contact with the mucous membrane for at least 1 minute. In numerous clinical studies, it has been shown that octenisept effectively acts bactericidally on various bacteria, including Gram-positive and Gram-negative bacteria. Antiseptics of the glans penis in menThe surfaces of the glans penis mucous membrane should be moistened with octenisept, ensuring contact with the mucous membrane for at least 1 minute. Disinfection of the oral cavityThe oral cavity should be rinsed intensively with 20 ml of octenisept for 20 seconds. Umbilical cord careFor umbilical cord care, a swab soaked in octenisept should be used. After 1 minute, the stump and the surrounding skin should be dried. The umbilical cord stump in children should be kept clean and dry.
In case of using a larger amount of the medicine than recommended or swallowing the medicine, you should immediately contact a doctor. In case of any further doubts related to the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although they may not occur in everyone. After moistening the vaginal mucous membrane, a feeling of heat or burning may occur in rare cases. When rinsing the oral cavity, a bitter taste persists for about 1 hour, which is related to the action of the medicine.
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help gather more information on the safety of the medicine.
Store in a temperature below 25°C. The medicine should be stored in a place out of sight and reach of children. Shelf life after first opening the packaging: 3 years. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month. Medicines should not be disposed of via wastewater or household waste containers. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are: octenidine dihydrochloride and phenoxyethanol. 100 g of the liquid contains 0.10 g of octenidine dihydrochloride and 2.00 g of phenoxyethanol. The other ingredients are: dimethylaminoacetic acid amidopropylcocoate, sodium D-glucuronate, glycerol 85%, sodium chloride, sodium hydroxide, purified water.
Octenisept is a clear, colorless, almost odorless solution for the skin. Packaging: A plastic bottle with a spray pump containing 50 ml of the solution, in a cardboard box with a leaflet attached to the packaging. A plastic bottle with a tamper-evident closure containing 250 ml of the solution. For more detailed information, you should contact the marketing authorization holder or parallel importer.
Schülke & Mayr GmbH, Seidengasse 9, A-1070 Vienna, Austria
Schülke & Mayr GmbH, D-22840 Norderstedt, Germany
Medezin Sp. z o.o., ul. Zbąszyńska 3, 91-342 Łódź
Medezin Sp. z o.o., ul. Zbąszyńska 3, 91-342 Łódź, CEFEA Sp. z o.o. Sp. komandytowa, ul. Działkowa 56, 02-234 Warsaw, SHIRAZ PRODUCTIONS Sp. z o.o., ul. Tymiankowa 24/28, 95-054 Ksawerów, CANPOLAND SPÓŁKA AKCYJNA, ul. Beskidzka 190, 91-610 Łódź, Marketing authorization number in Austria, the country of export: 1-20402, Parallel import authorization number: 314/22, Date of leaflet approval: 24.08.2022, [Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.